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ocking proteins are substrates of tyrosine kinases
and function in the recruitment and assembly of
specific signal transduction molecules. Here we
found that p62dok family members act as substrates for the
c-Ret receptor tyrosine kinase. In addition to dok-1, dok-2,
and dok-3, we identified two new family members, dok-4
and dok-5, that can directly associate with Y1062 of c-Ret.
Dok-4 and dok-5 constitute a subgroup of dok family mem-
bers that is coexpressed with c-Ret in various neuronal tis-
sues. Activated c-Ret promotes neurite outgrowth of PC12
cells; for this activity, Y1062 in c-Ret is essential. c-Ret/dok
D
 
fusion proteins, in which Y1062 of c-Ret is deleted and re-
placed by the sequences of dok-4 or dok-5, induce ligand-
dependent axonal outgrowth of PC12 cells, whereas a c-Ret
fusion containing dok-2 sequences does not elicit this re-
sponse. Dok-4 and dok-5 do not associate with rasGAP or
Nck, in contrast to p62dok and dok-2. Moreover, dok-4 and
dok-5 enhance c-Ret–dependent activation of mitogen-acti-
vated protein kinase. Thus, we have identified a subclass of
p62dok proteins that are putative links with downstream ef-
fectors of c-Ret in neuronal differentiation.
 
Introduction
 
The receptor tyrosine kinase c-Ret was discovered as an on-
cogene and is mutated in patients with multiple endocrine
neoplasia (MEN)2A,* MEN2B, and familial medullary thy-
roid carcinoma cancer syndromes (Takahashi et al., 1985;
Donis-Keller et al., 1993; Mulligan et al., 1993; Hofstra et
al., 1994). In addition, c-Ret and its ligand glial-derived neu-
rotrophic factor (GDNF) play essential roles in embryogene-
sis. Ablation of the GDNF or c-Ret genes in mice results in
absence or severe hypoplasia of the kidneys. Moreover, de-
velopment of neural crest cells and their derivatives is im-
paired and, as a consequence, portions of the enteric nervous
system are not formed and the number of neurons of several
peripheral ganglia is reduced (Schuchardt et al., 1994;
Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996).
Similarly, inactivating mutations of c-Ret in humans can
cause Hirschsprung’s disease, which is characterized by hy-
poplasia of the enteric nervous system (Edery et al., 1994;
Romeo et al., 1994). Two different isoforms of c-Ret exist as
a result of alternative splicing; both isoforms promote differ-
entiation of PC12 cells when activated (Rossel et al., 1997).
Activated c-Ret recruits signaling proteins like Grb7/Grb10,
PLC
 

 
, Shc/Enigma and Grb2, which bind to phosphory-
lated tyrosine residues in its COOH-terminal sequence,
Y905, Y1015, Y1062, and Y1096, respectively (Asai et al.,
1996; Borrello et al., 1996; Durick et al., 1996; Arighi et al.,
1997; Lorenzo et al., 1997; Alberti et al., 1998). Recent
work has shown that Shc binding to c-Ret recruits com-
plexes consisting of Grb2, Gab1/2, SHP-2, and phosphoti-
dyl inositol 3 kinase in addition to Grb2-Sos (Besset et al.,
2000; Hayashi et al., 2000). The docking site Y1062 of
c-Ret constitutes a consensus phosphotyrosine binding (PTB)
interaction site and has been shown to be essential for mito-
genic signaling by MEN2A and MEN2B c-Ret mutants
(Asai et al., 1996). However, the function of Y1062 in mor-
phogenic signaling and recruitment of specific substrates for
c-Ret signaling has not been explored.
The specificity of receptor tyrosine kinase signaling has
been investigated in great detail. A variety of substrates are
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shared by several receptors (Ullrich and Schlessinger, 1990;
van der Geer et al., 1994). In addition, specific docking pro-
teins of receptor tyrosine kinases have been discovered which
mediate particular biological responses. Insulin receptor sub-
strate (IRS)-1 and IRS-2 are two essential substrates of the
insulin receptor and, accordingly, ablation of the 
 
IRS-2
 
 gene
in mice results in diabetes (Sun et al., 1991, 1995; Withers
et al., 1998). Gab1 is important for signaling of c-Met; 
 
Gab-
 
1
 
–deficient mice exhibit a phenotype similar to c-Met
 

 
/
 

 
mice, i.e., embryonal lethality and impaired migration of
myogenic precursor cells (Bladt et al., 1995; Weidner et al.,
1996; Sachs et al., 2000). Moreover, FRS2 mediates FGF
and Trk receptor signaling in cells (Kouhara et al., 1997;
Meakin et al., 1999). Similarly, dos in 
 
Drosophila
 
 is essential
in sevenless signaling (Herbst et al., 1996; Raabe et al.,
1996). These docking proteins contain NH
 
2
 
-terminal mem-
brane-targeting elements, pleckstrin homology (PH) domains
or myristylation sites, and receptor-targeting sequences,
PTB or PTB-like domains. In addition, docking proteins
harbor multiple consensus binding sites for SH2 and SH3
containing molecules.
Several recent reports implicate the previously identified
dok members, p62dok (dok-1), dok-2, and dok-3, in neg-
ative regulation of signaling pathways activated by tyro-
sine kinases. These doks inhibit mitogen-activated protein
(MAP) kinase signaling, cell proliferation, and cellular trans-
formation (Cong et al., 1999; Suzu et al., 2000; Tamir et al.,
2000). The closely related p62dok and dok-2 may exert
their inhibitory effects by recruitment of rasGAP, a negative
regulator of ras signaling. Dok-2 can also attenuate EGF re-
ceptor (EGFR)-induced MAP kinase activation, indepen-
dent of its association with rasGAP (Jones and Dumont,
1999). Also, dok-3 is a negative regulator of immune recep-
tor and v-Abl signaling without binding rasGAP, but re-
cruiting SHIP and Csk (Cong et al., 1999; Lemay et al.,
2000). The p62dok family members resemble docking pro-
teins in their structure, since they contain PH and PTB do-
mains as well as multiple SH2 and SH3 binding sites (Car-
pino et al., 1997; Yamanashi and Baltimore, 1997; Di
Cristofano et al., 1998; Nelms et al., 1998; Cong et al.,
1999). In the present study, we identified a new subgroup of
p62dok family members, dok-4 and dok-5, which associate
directly with the receptor tyrosine kinase c-Ret. We show
that dok-4 and dok-5 can function in c-Ret–mediated neu-
rite outgrowth. In contrast to p62dok and dok-2, dok-4 and
dok-5 do not bind rasGAP and play a positive role in activa-
tion of the MAP kinase pathway.
 
Results
 
Identification of p62dok family members 
as interaction partners of c-Ret
 
To identify new substrates that interact with the activated
c-Ret receptor tyrosine kinase, we carried out a modified
yeast two-hybrid screen (O’Neill et al., 1994; Weidner et al.,
1996). The bait vector encodes the cytoplasmic part of the
short isoform of c-Ret (Tahira et al., 1990), which includes
Y1062, plus the DNA binding and dimerization domain of
the LexA transcription factor. Since this bait dimerizes, its
tyrosine kinase is constitutively active and is phosphorylated
on tyrosine residues in yeast (data not shown). By screening
a mouse E10.5 cDNA library, we identified p62dok family
members, dok-2 and dok-3, and a novel cDNA clone, dok-4,
as direct c-Ret binding proteins (Fig. 1 a and data not
shown). An additional p62dok family member, dok-5, was
identified by low stringency hyridization. By searching Ex-
pressed Sequence Tag databases, we have also found human
dok-6, but failed to isolate the mouse homologue (data not
shown). In the yeast two-hybrid assay, dok-5 and -6 also in-
teract with c-Ret. A mutation of tyrosine 1062 in the c-Ret
sequence abolishes binding to all dok family members (Fig.
1 a and data not shown). Moreover, dok proteins bind to
c-Ret in a phosphorylation-dependent manner, since a ki-
nase-defective receptor, K758M, does not interact. We also
examined interaction of p62dok family members with other
tyrosine kinase receptors. Dok-2 binds to c-Ret, Tie-2, and
weakly to the EGFR, but not to other receptors like Met,
Kit, Fms, Ros, TrkA, ErbB-2, and ErbB-3 (Fig. 1, b and c).
Dok-4 displays a similar specificity, except that it does not
bind to the EGFR (Fig. 1, a and c; see also below).
We isolated the complete cDNAs of five dok family mem-
bers, mouse dok-1–5. All dok members contain NH
 
2
 
-termi-
nal PH and central PTB domains; the PTB domains medi-
ate receptor interaction (see below). The COOH-terminal
sequences vary in length and show only limited sequence
identity (Fig. 2 a). Dok proteins contain tyrosine residues
within consensus binding sites for SH2 domains and several
PXXP SH3 binding motifs. The deduced amino acid se-
quences of the new dok members, dok-4 and dok-5, are
shown in Fig. 2, b and c; the sequences of dok-1–3 have
been reported previously (Carpino et al., 1997; Yamanashi
and Baltimore, 1997; Di Cristofano et al., 1998; Jones and
Dumont, 1998; Nelms et al., 1998; Cong et al., 1999). A
dendrogram of deduced amino acid sequences of the PTB
domains of the doks shows that dok-4/5 and dok-1/2, re-
spectively, are closely related (Fig. 2 d).
 
Dok family members are differentially expressed
 
In situ hybridization of E12.5 and E13.5 mouse embryos
showed that dok-4 is expressed in the central and peripheral
nervous system and in endothelia (Fig. 3, a, d, g, and h).
Sites of expression in the nervous system are the ventral por-
tion of the neural tube and the dorsal root and cranial sen-
sory ganglia. Dok-5 is also expressed in the nervous system,
e.g., in the neural tube and the dorsal root and cranial gan-
glia, but not in endothelia (Fig. 3, b and e). The expression
of these doks appears to be specific for neurons, since intense
punctate signals are observed in large neuronal cells of the
dorsal root ganglia and are absent from the glial cells lining
the emerging spinal nerves (data not shown). Potential over-
laps between dok-4/5 and c-Ret are thus seen in the ventral
part of the neural tube and in the dorsal root, the trigeminal
and geniculate ganglia (Fig. 3, c and f). c-Ret expression at
this stage of development is restricted to a subset of large
neurons; however, the number of small c-Ret neurons in-
creases with age (data not shown; Molliver et al., 1997). In
the kidney, dok-4 is expressed in endothelia, whereas c-Ret
is expressed in the growing tips of the ureter epithelium (Fig.
3, i and j). The other dok family members, dok-1–3, are
mainly expressed in hematopoietic tissues (Carpino et al.,
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1997; Nelms et al., 1998; Lemay et al., 2000). For instance,
dok-2 is found in a punctuate pattern in the embryonal
liver, consistent with an expression in hematopoietic precur-
sors (Fig. 3 k and data not shown). Northern blotting indi-
cated that the expression of the various dok mRNAs is main-
tained in the respective adult tissues (Fig. 4 and data not
shown). Dok-4 is expressed broadly in many tissues, such as
brain, heart, lung, and kidney, consistent with its expression
in endothelia at earlier stages. Dok-5 is specifically expressed
in the brain. In contrast, Dok-2 is found in spleen and lung,
which are rich in hematopoietic cell types.
The cellular association of c-Ret with dok family members
was investigated by coimmunoprecipitation using 293 cells.
Dok proteins bind to wild-type c-Ret, which is phosphory-
lated upon overexpression (Fig. 5 a). The new dok proteins,
dok-4 and dok-5, exhibit apparent molecular weights of 41
and 36 k, respectively (Fig. 5 a). All dok proteins tested are
phosphorylated by endogenous c-Ret upon GDNF stimula-
tion, and they also associate with the endogenous c-Ret re-
ceptor (shown for dok-2 and dok-5 in Fig. 5 b). Binding of
the doks to c-Ret is mediated by their PTB domain and re-
Figure 1. Interaction of dok family members with c-Ret and other 
receptor tyrosine kinases in the yeast two-hybrid system. Growth 
of yeast on selective medium. (a) Dok-2, -4, and -5 interact with 
wild-type c-Ret, but not with c-Ret receptors harboring a Y1062F 
mutation or an inactive kinase (Ret K, K758M; Liu et al., 1996). (b) 
Dok-2 interacts with c-Ret and Tie-2, but not with other receptor ty-
rosine kinases tested. Lam, lamin. (c) Dok-2, but not dok-4, interacts 
weakly with the EGFR but not other members of the EGFR family.
Figure 2. The dok protein family and newly identified dok members. 
(a) Domain structure of dok family members. PH and PTB domains are 
marked grey and black, and the positions of tyrosine residues (Y) and 
PXXP motifs (P) are indicated. (b and c) Deduced amino acid se-
quences of mouse dok-4 and dok-5, respectively. PH domains are 
boxed and PTB domains are underlined. (d) Phylogenetic tree of 
dok family members. Sequences of the PTB domains were aligned.
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quires phosphorylation of Y1062 (shown for dok-5 in Fig. 5
c). Interaction between the doks and c-Ret is direct, as dem-
onstrated by far Western blotting (Fig. 5 d). We could also
show interaction of dok-5 and c-Ret in vivo: in extracts of
spinal cords and dorsal root ganglia from newborn mice,
c-Ret was coimmunoprecipitated with dok-5 by using a
dok-5–specific antiserum (Fig. 5 e). We also tested whether
dok-4 associates with endothelial receptor tyrosine kinases.
Indeed, dok-4 coprecipitates with Tie-2, but not the VEGF
receptors 1, 2, and 3 (Fig. 5 f).
Figure 3. Expression of dok family 
members and c-Ret in mouse embryos. 
Whole-mount in situ hybridization of 
E12.5 and E13.5 mouse embryos fol-
lowed by semithin sectioning. (a, d, and 
g–i) Labeling with a dok-4–specific 
probe. Dok-4–positive cells are ob-
served in the ventral part of the spinal 
cord (sc), the dorsal root ganglia (drg), 
the trigeminal (tg) and geniculate ganglia 
(ge), and in endothelia (arrowheads). g–i 
are sections through lung, tail, and kid-
ney, respectively. (b and e) Labeling 
with a dok-5–specific probe. (c, f, and j) 
Labeling with a c-Ret–specific probe. 
Panel j shows expression in the buds of 
the ureter epithelium in the kidney. (k) 
Whole-mount in situ hybridization with 
a dok-2–specific probe. Dok-2 is specifi-
cally expressed in islands of cells within 
the embryonal liver (li). Bars, 0.2 mm.
Figure 4. Northern blotting of dok and 
c-Ret transcripts in adult mouse tissues. 
cDNA probes specific for dok-4 (a),
dok-5 (b), dok-2 (c), c-Ret (d), or actin 
were used. The positions of the tran-
scripts are indicated by arrows.
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Dok-4 and dok-5 mediate c-Ret–dependent 
neuronal differentiation of PC12 cells
 
Stimulation of c-Ret, but not the EGFR, induces axonal out-
growth in PC12 cells (Treanor et al., 1996). However, a chi-
meric receptor that contains the extracellular domain of the
EGFR fused to the intracellular domain of c-Ret can induce
axonal outgrowth in an EGF-dependent manner (Santoro et
al., 1994; Rizzo et al., 1996; see also Fig. 6 a). In contrast, the
Y1062F mutant EGFR/c-Ret hybrid, which does not bind
dok proteins, is not efficient in inducing axonal outgrowth
(Fig. 6 a, see statistics and expression levels of hybrid recep-
tors in Fig. 6 d). To determine if activation of dok family
members by c-Ret induces neuronal differentiation, we fused
sequences of dok-4 to an EGFR/c-Ret hybrid that lacks the
22 COOH-terminal amino acids including tyrosine 1062.
The dok-4 sequence used also lacks the region encoding the
PH domain. Indeed, this fusion receptor, EGFR/c-Ret-dok-4,
strongly induces axonal outgrowth of PC12 cells upon stimu-
lation with EGF (Fig. 6, b and d). In addition, receptor fu-
sions that contain only COOH-terminal sequences of dok-4
downstream of the PTB domain, or dok-5, promote neurite
outgrowth (Fig. 6, b–d). In contrast, an EGFR/c-Ret hybrid
fused to dok-2 is ineffective in this assay (Fig. 6, c and d).
These data indicate that the newly identified dok members,
dok-4/5, are putative links with downstream effectors of
c-Ret involved in neuronal differentiation.
Figure 5. Interaction and phosphoryla-
tion of dok family members by c-Ret 
and Tie-2 in mammalian cells. (a) Coim-
munoprecipitation of c-Ret with dok 
family members in 293 cells. Flag-
tagged doks and c-Ret were transfected, 
and immune complexes were precipi-
tated and immunoblotted with anti-Ret 
or anti-PY antibodies. Expression and 
phosphorylation of dok family members 
and c-Ret is shown in the lower gels. (b) 
Dok-2 and dok-5 are tyrosine phosphor-
ylated by endogenous c-Ret upon GDNF 
stimulation in Neuro 2A cells. Cells sta-
bly expressing GFR1 were used. (c) 
Coimmunoprecipitation of the PTB do-
main of dok-5 (amino acids 109–261) 
and c-Ret constructs. Expression levels 
and phophorylation are shown in the 
lower gels. (d) Far Western blot demon-
strating direct interaction of dok-5 with c-Ret but not mutant c-Ret. (e) A dok-5–specific antibody recognizes dok-5 in transfected 293 cells 
and in preparations of spinal cord and dorsal root ganglia, which also express c-Ret (top). The anti–dok-5 antibody coimmunoprecipitates 
phosphorylated c-Ret in extracts of spinal cords and dorsal root ganglia (bottom). (f) Coimmunoprecipitation of Tie-2 and dok-4 in 293 cells. 
Flag-tagged dok-4 and endothelial receptor tyrosine kinases were transfected, and immune complexes were precipitated and immunoblotted 
with anti-PY antibodies. Expression of phosphorylated receptors and dok-4 is shown in the lower gels.
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Previous investigations have shown that p62dok and dok-2
associate with rasGAP, and inhibit the MAP kinase pathway
(Jones and Dumont, 1999; Tamir et al., 2000; Yamanashi et
al., 2000). In contrast, we found that the newly identified
dok members, dok-4 and dok-5, do not associate with ras-
GAP, and also not with Nck (Fig. 7 a). Also, when fused to
c-Ret, dok-4 and dok-5 activate the MAP kinase pathway, as
demonstrated by Erk1/2 phosphorylation (Fig. 7 b). An Elk-
1–dependent promoter is also activated by dok-4/5 (Fig. 7 c),
whereas hybrids containing dok-2 are inactive in these assays.
Remarkably, expression of dok-2 inhibited GDNF-induced
activation of the Elk-1 reporter (Fig. 7 d). Dok-2 also
blocked Elk-1 activity induced by MEN2A Ret, an oncogen-
ically activated c-Ret receptor, whereas dok-5 did not (Fig. 7
e). These results suggest that dok-4 and dok-5 are not only
differently expressed, but can also activate different signaling
pathways than the dok family members identified previously.
 
Discussion
 
Here we have identified a novel subfamily of dok multi-
adapter proteins, dok-4 and dok-5, which are putative links
with downstream effectors of c-Ret signaling. Yeast two-
hybrid analysis and coimmunoprecipitation demonstrated
that dok family members, through their PTB domains, bind
directly to phosphorylated tyrosyl 1062 of Ret and become
phosphorylated themselves. Interaction of doks and c-Ret
could also be demonstrated in tissues of the spinal cord and
dorsal root ganglia. Many other receptors, such as Met, Kit,
Fms, Ros, TrkA, and ErbB-2, do not interact directly with the
doks. Dok-4 and dok-5 are coexpressed with c-Ret in neu-
ronal tissues. Moreover, PC12 cells that express c-Ret/dok-4
and c-Ret/dok-5 hybrids produce neurite outgrowth upon
stimulation by ligands. These data suggest that the novel doks
can mediate signals required for neuronal differentiation.
The expression of the new dok family members overlap
with c-Ret in tissues of the central and peripheral nervous
system. A function of c-Ret signaling in the nervous system
has been demonstrated by genetic experiments. For instance,
the number of sensory neurons of dorsal root ganglia and
motor neurons of the spinal cord is reduced in GDNF-defi-
cient mice (Moore et al., 1996; Sanchez et al., 1996). Abla-
tion of neurturin, another ligand of c-Ret, leads to loss of
cells in dorsal root and trigeminal sensory ganglia (Heucker-
oth et al., 1999). In addition, it has been shown that GDNF
and c-Ret play an important role in development of the en-
teric and sympathetic nervous system and the kidney (Schu-
chardt et al., 1994; Moore et al., 1996; Pichel et al., 1996;
Figure 6. Dok-4 and dok-5 mediate c-Ret–dependent neurite out-
growth. PC12 cells were transfected with retroviruses expressing 
constructs which encode the extracellular EGFR domain and intra-
cellular c-Ret/dok fusions, and neurite outgrowth was monitored af-
ter EGF treatment. (a) Cells expressing an EGFR/c-Ret hybrid or a hy-
brid containing a Y1062F mutation. (b) Cells expressing EGFR/c-Ret/
dok-4 fusions lacking Y1062 of c-Ret, or a construct only containing 
the COOH terminus of dok-4. (c) Cells expressing EGFR/c-Ret/dok-5 
or EGFR/c-Ret/dok-2 fusions. (d) Quantification of neurite outgrowth 
and a Western blot of hybrid receptor expression of experiments
a–c. Activated Ret induces neurite outgrowth, but not when Y1062 
is mutated. Also, Ret fusions with dok-4 and dok-5, but not dok-2, 
promote axonal outgrowth. For this activity, only the COOH termi-
nus of dok-4 downstream of the PTB domain is required.
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Sanchez et al., 1996). However, in the latter tissues, ex-
pression of dok family members does not overlap with
that of c-Ret. However, it is possible that additional dok
family members that are expressed at these sites exist, or
that other adapters take over dok functions. Thus, we sug-
gest that the newly identified dok proteins, dok-4 and
dok-5, can mediate c-Ret signals in a subset of neuronal
tissues. Dok family members are also expressed in other
tissues where c-Ret expression is weak or has not been de-
scribed (Pachnis et al., 1993; Avantaggiato et al., 1994).
For instance, dok-4 is strongly expressed in the vascular
endothelium. We found that dok-4 can also associate with
the endothelial Tie-2 receptor, suggesting that dok-4 may
function as a substrate for Tie-2 in endothelia. Tie-2 has
already been reported to associate with Dok-2 (Jones and
Dumont, 1998); however, endothelial expression of dok-2
is not pronounced and we have not been able to detect ex-
pression in this cell type.
Figure 7. Dok-4 and dok-5 do not asso-
ciate with rasGAP or Nck, and mediate 
MAP kinase and Elk-1 transactivation. 
(a) Coimmunoprecipitation of dok family 
members and rasGAP or Nck in 293 
cells in the presence and absence of
c-Ret. Flag-tagged doks were transfected, 
and immune complexes with endoge-
nous rasGAP and Nck were precipitated 
and immunoblotted. Phosphorylation of 
dok family members by c-Ret is shown 
in the lower gel. (b) Western blot dem-
onstrating activation of Erk1/2 by fusion 
constructs of EGFR/c-Ret with dok-4 and 
dok-5 but not dok-2. PC12 cells from ex-
periment shown in Fig. 6 were used, and 
Erk-1/2 phosphorylation was deter-
mined by a specific antibody. (c) Elk-1 
transactivation by fusion constructs of 
EGFR/c-Ret with dok-4 and dok-5 but 
not dok-2. Neuro 2A cells were transiently transfected with the indicated constructs together with Elk-1/Gal4 and Gal4-luciferase reporter 
plasmids. Cells were treated with EGF for 5 h and Luciferase activity was then determined. (d) Inhibition of c-Ret–induced Elk-1 activation by 
dok-2. 293 cells were transfected with c-Ret, increasing amounts of dok-2 and reporter plasmids. Cells were stimulated for 5 h with 50 ng/ml 
GDNF and 0.5 g/ml soluble GFR1. (e) Inhibition of MEN2A Ret induced activation of Elk-1 by dok-2 but not dok-5. 293 cells were trans-
fected with Ret C634R, increasing amounts of dok-2 or dok-5, and reporter plasmids. Luciferase activity was determined 48 h posttransfection.
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Other members of the dok family, dok-1–3, are mainly
expressed in hematopoietic tissues. Several recent reports
suggest an involvement of these dok proteins in lymphoid
signaling: p62dok and dok-2 are strongly tyrosine phosphor-
ylated in Bcr-Abl–transformed myelogenous leukemia cells
(Carpino et al., 1997; Yamanashi and Baltimore, 1997; Di
Cristofano et al., 1998). Dok-2 (dok-R/FRIP) also binds di-
rectly to the IL-4 receptor (Nelms et al., 1998). It is also
possible that hematopoietic dok proteins act as c-Ret sub-
strates in lymphoid cells, since recent reports suggest an in-
volvement of c-Ret in hematopoietic differentiation (Was-
serman et al., 1995; Gattei et al., 1997, 1998, 1999;
Nakayama et al., 1999). Phoshorylation of p62dok after
c-Ret activation can also occur in a phosphotidyl inositol 3
kinase–dependent manner (Murakami et al., 1999).
Dok family members have the typical features of multi-
adapter proteins such as membrane localization sequence
(PH domain), receptor interaction domain (PTB domain),
and several putative binding sites for downstream substrates
(P-tyr and PXXP elements). The importance of direct asso-
ciation of particular substrates with specific receptor tyrosine
kinases for activation of various signaling pathways has been
demonstrated recently, e.g., IRSs are essential for insulin re-
ceptor function, FRS2 is important for fibroblast growth
factor receptor and Trk signaling, and Gab-1 is an essential
substrate for c-Met (Sun et al., 1991, 1995; Weidner et al.,
1996; Kouhara et al., 1997; Sachs et al., 2000; Schaeper et
al., 2000). c-Ret can directly associate with all dok family
proteins. However, dok family members have distinct ex-
pression patterns. Differential expression of these adapter
proteins thus adds another layer to the complexity and spec-
ificity of signal transduction by receptor tyrosine kinases.
Members of the hematopoietically expressed doks, dok-1
and dok-2, contain long COOH-terminal sequences with
many tyrosyls and PXXP motifs adjacent to the PTB do-
main (e.g., 10 for dok-1). These doks have been shown to
associate with rasGAP, c-Abl, and Nck (Holland et al.,
1997; Yamanashi and Baltimore, 1997). Several recent re-
ports suggest a negative role of these dok proteins in the reg-
ulation of MAP kinase (Nelms et al., 1998; Jones and Du-
mont, 1999; Noguchi et al., 1999; Yamanashi et al., 2000).
The dok-4/5 proteins newly identified here contain short
COOH-terminal tails with fewer tyrosyls and few or no
PXXP motifs, and do not bind rasGAP or Nck. Moreover,
when dok-4 and dok-5 are fused to c-Ret, they strongly in-
duce MAP kinase and Elk-1 transactivation and trigger ax-
onal outgrowth. Thus, the two subfamilies of the dok pro-
teins, dok-1–3 and dok-4/5, appear to take over opposite
signaling functions in cells.
 
Materials and methods
 
Yeast two-hybrid screens and protein interaction studies
 
The cDNA encoding the cytoplasmic domain of the short isoform of
mouse c-Ret (amino acids 660–1,072) was fused to LexA sequences in the
yeast expression vector BTM116 (Weidner et al., 1996). Other LexA-tyro-
sine kinase hybrids were constructed similarly. In the case of the ErbB fam-
ily of receptors, COOH-terminal tails were inserted downstream of a
LexA–tpr–met construct, which lacks substrate binding sites of Met (EGFR,
amino acids 983–1,210; ErbB-2, amino acids 1,005–1,260; ErbB-3, amino
acids 980–1,342; tpr-met, amino acids 1–480). Yeast two-hybrid screens
 
were performed in yeast strain L40 using a E10.5 mouse embryo cDNA li-
brary (Behrens et al., 1996). For coimmunoprecipitation and tyrosine phos-
phorylation studies, 293 and Neuro 2A cells were transfected by standard
calcium phosphate precipitation, solubilized in lysis buffer (150 mM NaCl,
1mM EDTA, 50 mM Hepes, pH 7.5, 1% Triton X-100, 10% glycerol), and
proteins were precipitated with anti-Flag affinity agarose (Sigma-Aldrich)
followed by SDS-PAGE and immunoblotting. For far Western blotting, 293
cells were transiently transfected with c-Ret constructs, followed by immu-
noprecipitation with c-Ret antibodies, SDS-PAGE, and blotting. Mem-
branes were probed with 250 nM purified His-tagged dok-5 protein
(amino acids 16–306) and developed with anti-His antibody. Antibodies
used were anti-Ret C-19 and anti-rasGAP B4F8 (Santa Cruz Biotechnology,
Inc.), anti-Nck and anti-PY PY20 (Transduction Laboratories), anti-Flag
Octapeptide (Zymed Laboratories), antiactive MAP kinase (Promega), per-
oxidase-conjugated anti-His (Sigma-Aldrich), and horseradish peroxidase–
conjugated anti-IgG (Jackson ImmunoResearch Laboratories). An antise-
rum against dok-5 was prepared in rabbits by immunization with a mixture
of two peptides (amino acids 247–257 and 292–306) and was affinity puri-
fied. Spinal cords and dorsal root ganglia were prepared from P1 mouse
embryos, solubilized in lysis buffer, and immunoprecipitations with anti–
dok-5 antibodies were performed as described above.
 
In situ
 
 
 
hybridization and Northern blotting
 
Digoxygenin-labeled RNA transcripts were synthesized with T3 or T7 RNA
polymerase using a digoxygenin RNA–labeling kit (Boehringer). Whole-
mount in situ hybridization was performed as described (Wilkinson, 1992).
Probes used were: c-Ret, nt 1–1,445; dok-4, entire coding sequence plus
900 3
 
 
 
nucleotide sequences; dok-5, entire coding sequence plus 180 5
 

 
nucleotides; dok-2, nucleotides 469–890. All probes revealed reproduc-
ible hybridization patterns when used in antisense orientation, whereas
transcripts in sense orientation revealed no specific hybridization. Semi-
thin serial sections (7–15 
 

 
m) were prepared from the whole-mounts em-
bedded in Technovit 7100 (Kulzer GmbH). Mouse multiple tissue North-
ern blots (CLONTECH Laboratories, Inc.) were probed with 
 
32
 
P-labeled
cDNA probes specific for dok family members prepared by the Megaprime
DNA labeling kit (Amersham Pharmacia Biotech).
 
Construction of EGFR/c-Ret-dok chimeras 
and generation of PC12 transfectants
 
EGFR/c-Ret constructs were inserted into the SalI site of pBabe Puro retro-
viral expression vector (Morgenstern and Land, 1990); in EGFR/c-Ret
Y1062F, tyrosine residue 1,062 was mutated to phenylalanin by PCR. Fu-
sion constructs of EGFR/c-Ret and various dok family members were gen-
erated by insertion of dok fragments (encoding amino acids 119–412, dok-2;
113–325, dok-4; 116–306, dok-5; and 233–325, dok-4Cterm) into the
XhoI site of c-ret, deleting sequences encoding the last 22 amino acids of
c-Ret including Y1062. PC12 cells were infected with high titer stock of a
retrovirus that contained the EGFR/c-Ret-dok constructs, and were selected
for 5 d with 0.5 
 

 
g/ml puromycin. Pools of selected cultures were grown
in the presence or absence of 50 ng/ml EGF for 48 h, and neurite out-
growth was quantitated by scoring cells with neurites longer than the size
of two cell bodies.
 
MAP kinase and Elk-1 reporter assays
 
PC12 cells infected with retroviruses were serum-starved overnight and
then treated with and without 50 ng/ml EGF for 9 h. Cells were lysed and
assayed for Erk1/2 phosphorylation using the antiactive MAP kinase anti-
body. Neuro 2A cells were transfected with pBabe EGFR/c-Ret-dok expres-
sion plasmids, pFA2-Elk1, pFRLuc (Stratagene), and pSV40lacZ expression
vectors. 2 d posttransfection, cells were stimulated with 50 ng/ml EGF for
5 h. 293 cells were transfected with c-Ret or MEN2A Ret (C634R), different
amounts of dok-2 or dok-5, and reporter plasmids. Cells were lysed 2 d
posttransfection by three freeze and thaw cycles, and extracts were ana-
lyzed for 
 

 
-galactosidase and luciferase activity.
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